Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
IBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
BBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
BCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 32 | Lindgardt ZhenyaDirector, Chief Executive Officer |  SERASERA PROGNOSTICS, INC.Open-market sale | SELL | $40K 20.1K sh | Sep 9, 2026 |
| 32 | Clerc AlexandreSVP, Customers |  ULCCFrontier Group Holdings, Inc.Open-market sale | SELL | $20K 3,480 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 31 | Lin Elizabeth YeuChief Medical Officer |  TARSTarsus Pharmaceuticals, Inc.Open-market sale · 10b5-1 plan | SELL | $458K 5,387 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 30 | Phillips DominicSEE REMARKS | IOTSamsara Inc. Open-market sale · 10b5-1 plan | SELL | $518K 11.7K sh | Sep 9, 2026 traded Sep 4, 2026 |
| 30 | Phillips DominicSEE REMARKS | IOTSamsara Inc. Open-market sale · 10b5-1 plan | SELL | $793K 17.9K sh | Sep 9, 2026 traded Sep 4, 2026 |
| 29 | Tepper OrenCRO |  NYAXNayax Ltd.Open-market sale | SELL | $3,368 65 sh | Sep 9, 2026 traded Sep 8, 2026 |
| 29 | Crook Nathaniel GlennChief Commercial Officer |  AMPLAmplitude, Inc.Open-market sale · 10b5-1 plan | SELL | $3.90M 300.0K sh | Sep 9, 2026 traded Sep 4, 2026 |
| 28 | Landman YoavDirector, CHIEF TECHNOLOGY OFFICER |  FROGJFrog LtdOpen-market sale · 10b5-1 plan | SELL | $1.41M 16.1K sh | Sep 9, 2026 traded Sep 4, 2026 |
| 28 | Meriweather Tiffany N.Chief Admin. & Legal Officer |  FIVNFive9, Inc.Open-market sale · 10b5-1 plan | SELL | $262K 7,809 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 28 | Landman YoavDirector, CHIEF TECHNOLOGY OFFICER | FROGJFrog Ltd Open-market sale · 10b5-1 plan | SELL | $1.30M 14.4K sh | Sep 9, 2026 traded Sep 4, 2026 |
| 28 | Lin Elizabeth YeuChief Medical Officer | TARSTarsus Pharmaceuticals, Inc. Open-market sale · 10b5-1 plan | SELL | $135K 1,590 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 28 | Budur KumarCHIEF MEDICAL OFFICER |  HRMYHarmony Biosciences Holdings, Inc.Open-market sale | SELL | $190K 4,500 sh | Sep 9, 2026 traded Sep 8, 2026 |
| 27 | Neervannan SeshadriChief Operating Officer | TARSTarsus Pharmaceuticals, Inc. Open-market sale · 10b5-1 plan | SELL | $388K 4,564 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 27 | Chen Sean ChihhsiangPresident and COO |  AMBQAmbiq Micro, Inc.Open-market sale · 10b5-1 plan | SELL | $735K 12.9K sh | Sep 9, 2026 traded Sep 4, 2026 |
| 26 | Wassil JimEVP, Chief Scientific Ofc, COO |  PCVXVaxcyte, Inc.Open-market sale | SELL | $84K 1,381 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 26 | Collier CharlesPresident, Roku Media | ROKUROKU, INC Open-market sale · 10b5-1 plan | SELL | $225K 1,426 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 26 | Collier CharlesPresident, Roku Media | ROKUROKU, INC Open-market sale · 10b5-1 plan | SELL | $225K 1,426 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 26 | Maguire Scott AndrewCOO |  ONONOn Holding AGOpen-market sale | SELL | $41K 1,475 sh | Sep 9, 2026 traded Sep 8, 2026 |
| 25 | Landman YoavDirector, CHIEF TECHNOLOGY OFFICER | FROGJFrog Ltd Open-market sale · 10b5-1 plan | SELL | $439K 4,800 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 25 | Landman YoavDirector, CHIEF TECHNOLOGY OFFICER | FROGJFrog Ltd Open-market sale · 10b5-1 plan | SELL | $631K 7,027 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 25 | Lee Bryan MChief Financial Officer | FIVNFive9, Inc. Open-market sale · 10b5-1 plan | SELL | $262K 7,813 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 25 | Meriweather Tiffany N.Chief Admin. & Legal Officer | FIVNFive9, Inc. Open-market sale · 10b5-1 plan | SELL | $185K 5,600 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 25 | Yoon William TChief Legal Officer |  DBXDROPBOX, INC.Open-market sale · 10b5-1 plan | SELL | $431K 12.4K sh | Sep 9, 2026 traded Sep 4, 2026 |
| 25 | Weingarten TomerDirector, President, CEO |  SSentinelOne, Inc.Open-market sale | SELL | $767K 38.8K sh | Sep 9, 2026 traded Sep 8, 2026 |
| 22 | Asmerom AmineChief Accounting Officer |  CHYMChime Financial, Inc.Open-market sale · 10b5-1 plan | SELL | $325K 10.0K sh | Sep 9, 2026 traded Sep 8, 2026 |
| 22 | Landman YoavDirector, CHIEF TECHNOLOGY OFFICER | FROGJFrog Ltd Open-market sale · 10b5-1 plan | SELL | $239K 2,700 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 22 | Lee Bryan MChief Financial Officer | FIVNFive9, Inc. Open-market sale · 10b5-1 plan | SELL | $167K 4,995 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 22 | Russotti GregorySee Remarks |  IPSCCentury Therapeutics, Inc.Open-market sale | SELL | $1,095 534 sh | Sep 9, 2026 traded Sep 8, 2026 |
| 22 | Dignan AndyPresident | FIVNFive9, Inc. Open-market sale · 10b5-1 plan | SELL | $96K 2,900 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 22 | Dignan AndyPresident | FIVNFive9, Inc. Open-market sale · 10b5-1 plan | SELL | $110K 3,295 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 22 | Lee Bryan MChief Financial Officer | FIVNFive9, Inc. Open-market sale · 10b5-1 plan | SELL | $215K 6,500 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 22 | Asmerom AmineChief Accounting Officer | CHYMChime Financial, Inc. Open-market sale · 10b5-1 plan | SELL | $317K 9,505 sh | Sep 9, 2026 traded Sep 8, 2026 |
| 22 | Dignan AndyPresident | FIVNFive9, Inc. Open-market sale · 10b5-1 plan | SELL | $147K 4,379 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 21 | Budur KumarCHIEF MEDICAL OFFICER | HRMYHarmony Biosciences Holdings, Inc. Open-market sale | SELL | $43K 1,000 sh | Sep 9, 2026 traded Sep 8, 2026 |
| 20 | Wassil JimEVP, Chief Scientific Ofc, COO | PCVXVaxcyte, Inc. Open-market sale | SELL | $79K 1,334 sh | Sep 9, 2026 traded Sep 9, 2026 |
| 20 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner |  PACSPACS Group, Inc.Open-market sale · 10b5-1 plan | SELL | $974K 22.8K sh | Sep 9, 2026 traded Sep 4, 2026 |
| 20 | Chen Sean ChihhsiangPresident and COO | AMBQAmbiq Micro, Inc. Open-market sale · 10b5-1 plan | SELL | $123K 2,126 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 20 | Pfeiffer DeborahEVP & Pres, Presort Services |  PBIPITNEY BOWES INC /DE/Open-market sale · 10b5-1 plan | SELL | $342K 20.0K sh | Sep 9, 2026 traded Sep 8, 2026 |
| 20 | Azamian Bobak R.Director, President/CEO and Board Chair | TARSTarsus Pharmaceuticals, Inc. Open-market sale · 10b5-1 plan | SELL | $265K 2,900 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 20 | Azamian Bobak R.Director, President/CEO and Board Chair | TARSTarsus Pharmaceuticals, Inc. Open-market sale · 10b5-1 plan | SELL | $641K 7,100 sh | Sep 9, 2026 traded Sep 4, 2026 |